ARCHIVES

AVEO’s Tivozanib Sunk by Fundamental Flaw: Higher Overall Survival in the Control Arm

This article is from The Cancer Letter archive.

Vol. 39 No. 18 | May 8, 2013

Download PDF Visit The Full Archive

Related Articles

Study Attributes Drop In Breast Cancer Incidence To Decline In Hormone Replacement.

December 15, 2006

Senate Committee To Debate Budget Bill Sept. 10; Increase Expected For Breast Cancer Research

September 4, 1992

NCI Grant Funding Payline To Begin At 16th Percentile In FY 2010

December 11, 2009

NTP Board Approves Concept Of Human Cell Assay For Genetic Toxicity

March 25, 1983

Relative Survival Now May be Over 50%, DeVita Says

December 3, 1982

Final Issue of 1981

December 11, 1981